- Home
- VNDA vs SLND Comparison
VNDA vs SLND Comparison
Compare VNDA & SLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- SLND
- Stock Information
- Founded
- VNDA 2002
- SLND 1900
- Country
- VNDA United States
- SLND United States
- Employees
- VNDA N/A
- SLND N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- SLND Military/Government/Technical
- Sector
- VNDA Health Care
- SLND Industrials
- Exchange
- VNDA Nasdaq
- SLND Nasdaq
- Market Cap
- VNDA 249.4M
- SLND 210.6M
- IPO Year
- VNDA 2006
- SLND N/A
- Fundamental
- Price
- VNDA $5.47
- SLND $4.50
- Analyst Decision
- VNDA Strong Buy
- SLND Buy
- Analyst Count
- VNDA 2
- SLND 2
- Target Price
- VNDA $16.50
- SLND $4.50
- AVG Volume (30 Days)
- VNDA 562.7K
- SLND 109.9K
- Earning Date
- VNDA 10-29-2025
- SLND 11-11-2025
- Dividend Yield
- VNDA N/A
- SLND N/A
- EPS Growth
- VNDA N/A
- SLND N/A
- EPS
- VNDA N/A
- SLND N/A
- Revenue
- VNDA $203,467,000.00
- SLND $895,438,000.00
- Revenue This Year
- VNDA $15.45
- SLND N/A
- Revenue Next Year
- VNDA $37.82
- SLND $3.50
- P/E Ratio
- VNDA N/A
- SLND N/A
- Revenue Growth
- VNDA 11.78
- SLND N/A
- 52 Week Low
- VNDA $3.81
- SLND $1.85
- 52 Week High
- VNDA $5.59
- SLND $4.90
- Technical
- Relative Strength Index (RSI)
- VNDA 63.56
- SLND 51.28
- Support Level
- VNDA $5.22
- SLND $4.28
- Resistance Level
- VNDA $5.45
- SLND $4.60
- Average True Range (ATR)
- VNDA 0.21
- SLND 0.24
- MACD
- VNDA -0.01
- SLND -0.01
- Stochastic Oscillator
- VNDA 73.96
- SLND 48.08
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About SLND Southland Holdings Inc.
Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures. The company operates in two distinct segments: Civil and Transportation. The civil segment operates throughout North America and specializes in services that include the design and construction of water pipelines, pump stations, lift stations, water and wastewater treatment plants, concrete and structural steel, outfall, and tunneling. The transportation segment operates throughout North America and specializes in services that include the design and construction of bridges, roadways, marine, dredging, ship terminals and piers, and specialty structures and facilities.